Navigation Links
Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA
Date:1/28/2008

Lopinavir/ritonavir tablet is the first and only co-formulated protease

inhibitor tablet approved for use in children with HIV

ABBOTT PARK, Ill., Jan. 28 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the European Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has issued a positive opinion recommending approval of a new, lower-strength tablet formulation of the company's leading HIV protease inhibitor, Kaletra(R) (lopinavir/ritonavir). In addition, the CHMP has adopted a positive opinion, in coordination with the World Health Organization (WHO), for Aluvia(R) (lopinavir/ritonavir), the tradename of the same lower-strength tablet formulation in developing countries.

The new lower-strength formulation is suitable for pediatric use and represents a significant breakthrough for clinicians and patients in developing countries, where more than 2 million of the estimated 2.3 million children worldwide with HIV/AIDS live. The first and only co-formulated protease inhibitor tablet that can be used in children, the tablets do not require refrigeration and can be taken with or without a meal -- an important advance in delivering HIV medicine in developing countries.

"EMEA approval is an essential first step to registering the tablet in Europe and most developing countries and it is welcome news for physicians and caregivers of children with HIV," said Mark Kline, M.D., professor of pediatrics, chief of Retrovirology, director, AIDS International Training and Research Program, and director, Baylor-CDC Global AIDS Technical Assistance Project, Baylor College of Medicine. "The development of this product, which does not require refrigeratio
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients
2. Ugandan Children Are Among the First to Receive Abbotts Lower-Strength Aluvia (lopinavir/ritonavir) Tablet
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Actavis Launches Carvedilol Tablets in the U.S.
6. Mylan Announces Final FDA Approval for Carvedilol Tablets
7. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
8. Actavis Launches Amlodipine Tablets in the U.S.
9. Tablet is better all round for cancer patients
10. Roxane Laboratories, Inc. Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg
11. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 06, 2015 As healthcare providers ... and content from disparate systems, they are using ... and increase efficiency. Enterprise content management ... with core IT solutions, including electronic medical records ... IT applications. , The following organizations have ...
(Date:3/6/2015)... “ Pokemini ” was featured on NewsWatch as ... coolest mobile applications on the iOS, Android, and Windows markets. ... conducted the app review and shared with viewers how this ... last couple of years, mobile games have benefited from building ... Candy Crush allows users to connect their games to Facebook, ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Saving Moses, ... around the world is traveling to Angola, Africa March ... of their malnutrition program. , This will be the ... in Angola, demonstrating their commitment to the region’s population ... The team will engage with the mothers and babies ...
(Date:3/6/2015)... 06, 2015 Ticket Down is a reputable ... at the Moda Center. After being away from ... is showing no signs of letting up on his “Garth ... and his wife, Trisha Yearwood, to venues around the United ... their critically acclaimed tour to the Moda Center in Portland, ...
(Date:3/6/2015)... 06, 2015 Follow us on ... pharmacokinetics of a drug refers to testing of absorption, ... an organism. When toxicity studies are clubbed together with ... ADME/Tox. Increasing focus on lowering costs and time during ... worldwide. The traditional drug development model uses toxicity and ...
Breaking Medicine News(10 mins):Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 2Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 3Health News:A Kawaii Social Game was Featured on NewsWatch Television on February 26, 2015 2Health News:Saving Moses Returns to Angola to Continue Giving Infants and Children a Chance to Live 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3
... ... Quorum Health Resources (QHR) management client Holy Cross Hospital in Taos, N.M., one of five ... ... has named Quorum Health Resources (QHR) management client Holy Cross Hospital in Taos, ...
... care physicians can improve the health of high-risk patients ... and treatment plan recommendations with primary care physicians, according ... British Medical Journal. , , ... specialists can take a more active role in managing ...
... technologies and enhanced caregiver training , , NEW ... (AFA), New York, NY, and Samarion Inc., Jackson, MS, ... to address the critical need for optimal dementia care ... programs for healthcare professionals. , , Samarion,s Enterprise ...
... hairstyles, oral piercings give teens and adults a way to ... of potential oral and overall health care risks. It,s also ... tongue, and also the lips, cheeks, uvula or a combination ... of adverse oral and systemic conditions. , , (Photo: ...
... July 9, 2009 UT Southwestern Medical Center ... Endo-Surgery, Inc. to develop a groundbreaking toolbox of magnetically ... The investigational surgical device platform includes a wide range ... maneuverability and range of motion while reducing the number ...
... 9 Mahindra Satyam, the new brand identity of Satyam ... global consulting and IT services provider, announced today that it ... to provide SAP and other critical systems support to GSK,s ... since 2002 to provide IT application development and support services. ...
Cached Medicine News:Health News:QHR Client Hospital Holy Cross Hospital Named Recipient of American Hospital Association 2009 NOVA Award 2Health News:Kaiser Permanente Project Proves Electronic Health Information and Care Coordination Improves Chronic Disease Management 2Health News:Kaiser Permanente Project Proves Electronic Health Information and Care Coordination Improves Chronic Disease Management 3Health News:Kaiser Permanente Project Proves Electronic Health Information and Care Coordination Improves Chronic Disease Management 4Health News:Alzheimer's Foundation of America and Samarion(SM) Form Strategic Alliance to Enhance Care for Individuals with Dementia 2Health News:Alzheimer's Foundation of America and Samarion(SM) Form Strategic Alliance to Enhance Care for Individuals with Dementia 3Health News:Oral Piercings Pose Potential Health Care Risks 2Health News:Oral Piercings Pose Potential Health Care Risks 3Health News:UT Southwestern, UT Arlington to develop magnetic surgery tools 2Health News:UT Southwestern, UT Arlington to develop magnetic surgery tools 3Health News:Mahindra Satyam Signs 5 Year SAP Contract with GlaxoSmithKline 2
(Date:3/6/2015)... Alemania, 6 de marzo de 2015 ... de gestión empresarial de imagen médica, fortalece su ... nombramiento de Randolph Sternberg como director ... como director de operaciones. Logo - ... será responsable de las ventas y desarrollo ...
(Date:3/6/2015)... , March 6, 2015 Lucerne ... Trademark Office,s publication of U.S. Patent Application No. ... ,249 Patent Application features claimed methods of "informing ... used to treat Binge Eating Disorder (,BED,)," including ... or "flyer or an advertisement," as well as ...
(Date:3/6/2015)... -- UNICANCER pourra identifier plus ... de l,innovation thérapeutique.   TEMIS ... pour l,Entreprise, annonce que sa solution Luxid® a ... lutte contre le cancer (CLCC), comme module sémantique ... Soin-Recherche) conduit par la société de conseil et ...
Breaking Medicine Technology:TeraRecon fortalece su posición en EMEA 2TeraRecon fortalece su posición en EMEA 3Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 2TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 3TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 4
... Jan. 20, 2011 TheCarrot.com , a ... engagement programs, announced the immediate availability of its ... of the University of California at San Francisco,s ... proven behavior modification methodology with TheCarrot.com,s award-winning online ...
... SYK ) announced today that it has been named ... in the magazine,s 14th annual survey of top-rated workplaces in the ... the list, and the company was ranked 68th out of 100; ... related stories will appear in the February 7 issue of FORTUNE, ...
Cached Medicine Technology:TheCarrot.com Launches Quit Smoking Program 2TheCarrot.com Launches Quit Smoking Program 3Stryker Corporation Named One of FORTUNE Magazine's '100 Best Companies to Work For' 2
... FingerPrint Sleep Hand-Held Pulse Oximeter with ... for sleep screening studies in the ... With its easy-to-use, 2-key operation, ... measurements of SpO 2 , pulse ...
... The BCI 3180 Pulse Oximeter is a ... SpO 2 pulse rate and pulse ... adult. This AC or battery powered ... low alarm limits and up to 30 ...
... Administration (FDA) has granted approval of Alcon's ... patients with and without presbyopia. This innovative ... to give patients a full range of ... greatly increases their independence from glasses after ...
Engineered for high volume surgical efficiencies, the Bausch & Lomb Hansatome Microkeratome, a corneal resection instrument, features an automated pivoting motion that provides smooth, resistance-fre...
Medicine Products: